# Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease

> **NCT01018940** · — · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 30 (actual)

## Conditions studied

- Coronary Artery Disease
- Peripheral Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01018940
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018940, "Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01018940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*